Cargando…

Phase 1 Study of the Pharmacology of BTI320 Before High‐Glycemic Meals

BTI320 is a proprietary fractionated mannan polysaccharide being studied for attenuation of postprandial glucose excursion. The apparent blood glucose‐lowering effect of this compound is effective in lowering postprandial hyperinsulinemia, participating in the metabolic regulation of other lipid mol...

Descripción completa

Detalles Bibliográficos
Autores principales: Luke, David R., Lee, Karen Ka Yan, Rausch, Carl W., Cheng, Camille
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585810/
https://www.ncbi.nlm.nih.gov/pubmed/29870598
http://dx.doi.org/10.1002/cpdd.583

Ejemplares similares